The CHN1 Gene Duane Retraction Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CHN1 gene, which are associated with Duane Retraction Syndrome (DRS). DRS is a rare congenital eye movement disorder characterized by limited horizontal eye movement, retraction of the eyeball into the socket, and, in some cases, other abnormalities. This condition results from abnormal development of the eye muscles, with the CHN1 gene playing a critical role in this process.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic anomalies in the CHN1 gene that might be responsible for the syndrome. This genetic testing is crucial for accurate diagnosis, helping in the management and treatment planning for individuals affected by DRS. It also offers valuable information for family planning to those who have a history of the syndrome in their family.
At DNA Labs UAE, the CHN1 Gene Duane Retraction Syndrome Genetic Test is priced at 4400 AED. This cost encompasses the entire process, from sample collection to genetic analysis and the provision of results. By offering this test, DNA Labs UAE provides an essential service for the early and accurate diagnosis of Duane Retraction Syndrome, facilitating better outcomes for those affected by this genetic condition.
The SALL4 Gene Duane Retraction Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SALL4 gene, which are linked to Duane Retraction Syndrome (DRS). This condition is a rare, congenital eye disorder characterized by limited horizontal eye movement, which often results in the retraction of the eyeball into the socket or other eye abnormalities. Early and accurate diagnosis through this genetic test allows for better management and understanding of the condition, potentially leading to more effective treatment plans and supportive care.
The test involves a detailed analysis of the SALL4 gene to pinpoint specific genetic alterations responsible for the syndrome. It is a critical step for families seeking answers about the genetic underpinnings of DRS and its potential impact on their health and development.
The cost of the SALL4 Gene Duane Retraction Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to accurately assess the presence of mutations in the SALL4 gene, providing essential insights for affected individuals and their families. The test is conducted in a state-of-the-art laboratory setting, ensuring high-quality standards and reliable results.
The ADAR Gene Dyschromatosis Symmetrica Hereditaria Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the ADAR gene, which are known to cause Dyschromatosis Symmetrica Hereditaria (DSH). DSH is a rare genetic disorder characterized by a mixture of hyperpigmented and hypopigmented macules, primarily affecting the back of the hands and feet, and sometimes the face. These skin changes usually appear in early childhood and can vary significantly in pattern and extent among affected individuals.
This genetic test is crucial for confirming a diagnosis of DSH, allowing for appropriate management and counseling. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect mutations in the ADAR gene that are indicative of the condition. The process is thorough and is carried out by highly skilled professionals who ensure the accuracy and confidentiality of the results.
The cost of the ADAR Gene Dyschromatosis Symmetrica Hereditaria Genetic Test at DNA Labs UAE is 4400 AED. While the price might seem steep, it reflects the sophisticated technology and expertise required to perform such a specialized test. For families and individuals facing the possibility of DSH, this test provides invaluable information that can guide decisions about treatment and management, as well as offer insights into the risk of passing the condition on to future generations.
The COL15A1 gene is implicated in a variety of biological processes and has recently been identified as a potential modifier for the phenotype of early-onset glaucoma. This discovery has paved the way for the development of specialized genetic testing aimed at identifying variations within the COL15A1 gene that may influence the risk and progression of glaucoma at an early age. The test is designed to provide individuals with a more personalized understanding of their glaucoma risk, potentially leading to earlier and more targeted interventions.
Conducted at DNA Labs UAE, this genetic test involves analyzing the DNA of individuals to detect specific mutations in the COL15A1 gene that are associated with early-onset glaucoma. By identifying these genetic markers, healthcare providers can better assess an individual's risk for developing glaucoma and tailor prevention or treatment strategies accordingly.
The cost of the COL15A1-related genetic test is 4400 AED. This investment allows individuals to gain valuable insights into their genetic predisposition towards early-onset glaucoma, enabling them to take proactive steps in managing their eye health. Given the significance of early detection and intervention in managing glaucoma, this test represents a critical tool in the fight against this potentially sight-threatening condition.
The ADAMTSL4 Gene Ectopia lentis et pupillae Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the ADAMTSL4 gene, which are linked to the rare condition known as ectopia lentis et pupillae. This condition is characterized by the displacement or malposition of the lens and pupil of the eye, leading to visual impairments and potentially impacting the quality of life of affected individuals. The test is particularly crucial for early detection, accurate diagnosis, and guiding appropriate management and treatment strategies for patients exhibiting symptoms related to this genetic disorder.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, this test provides a comprehensive evaluation of the ADAMTSL4 gene to identify specific genetic alterations. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately detect and interpret genetic variations associated with ectopia lentis et pupillae. By opting for this genetic test, patients and their families can gain valuable insights into the genetic underpinnings of the condition, enabling informed decisions regarding treatment options and genetic counseling. DNA Labs UAE ensures confidentiality, accuracy, and support throughout the testing process, making it a trusted choice for individuals seeking genetic testing services.
The FBN1 Gene Ectopia Lentis Familial Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the FBN1 gene, which are associated with familial ectopia lentis. Ectopia lentis is a condition characterized by the displacement or malposition of the eye's lens, which can lead to visual impairments. This condition is often hereditary and is linked to Marfan Syndrome and other connective tissue disorders, with the FBN1 gene playing a crucial role in the development of the body's connective tissues.
This genetic test is critical for individuals with a family history of ectopia lentis or related connective tissue disorders, as early identification of FBN1 gene mutations can facilitate timely intervention and management of the condition. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the FBN1 gene that are known to cause ectopia lentis.
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test is conducted in a state-of-the-art laboratory setting by experienced geneticists and laboratory technicians, ensuring high accuracy and reliability of the results. By opting for this test, individuals can gain valuable insights into their genetic predisposition to ectopia lentis and related conditions, enabling them to make informed decisions about their health and future.
The ADAMTSL4 gene ectopia lentis isolated autosomal recessive genetic test is a specialized diagnostic procedure designed to identify mutations in the ADAMTSL4 gene, which are known to cause isolated ectopia lentis in an autosomal recessive manner. Ectopia lentis refers to the dislocation or displacement of the eye's lens, a condition that can significantly affect vision. When caused by mutations in the ADAMTSL4 gene, the condition does not typically present with other systemic features, distinguishing it from syndromic forms of ectopia lentis.
This genetic test involves analyzing the patient's DNA to detect mutations in the ADAMTSL4 gene that are responsible for the condition. Early detection through this test can aid in the management and treatment of ectopia lentis, helping to prevent potential complications and improve quality of life for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a reliable and accurate means of diagnosis for families concerned about this inheritable eye condition. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results. By choosing DNA Labs UAE for this test, patients can expect high-quality service and comprehensive support throughout the testing process.
The LOXL1 Gene Exfoliation Syndrome Susceptibility Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify genetic predispositions to exfoliation syndrome (XFS), a significant risk factor for glaucoma. This condition is characterized by the accumulation of extracellular fibrillar material in the eye, leading to increased intraocular pressure and potential vision loss. The LOXL1 gene has been identified as a critical factor in the development of XFS, making this test a crucial tool for early detection and management of the syndrome.
The test involves analyzing the patient's DNA to detect mutations in the LOXL1 gene that are associated with an increased risk of developing exfoliation syndrome. Early identification of these genetic markers can enable proactive monitoring and intervention, potentially preserving vision by preventing the progression to glaucoma.
Priced at 4400 AED, the LOXL1 Gene Exfoliation Syndrome Susceptibility Genetic Test is accessible at DNA Labs UAE, where cutting-edge technology and expertise ensure accurate and reliable results. Individuals with a family history of glaucoma or exfoliation syndrome, or those exhibiting early symptoms, may particularly benefit from this test, enabling them to take timely steps towards eye health management.
The FZD4 Gene Exudative Vitreoretinopathy Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the FZD4 gene, which are linked to the development of Familial Exudative Vitreoretinopathy (FEVR). FEVR is a hereditary disorder affecting the growth and development of the retinal vasculature, leading to vision impairment or blindness. The test is crucial for individuals with a family history of the disorder or those exhibiting symptoms, providing essential information for early intervention and management of the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the FZD4 gene and offering a pathway towards personalized treatment plans for affected individuals.
The NDP Gene Exudative Vitreoretinopathy Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the NDP gene, which are linked to the development of Exudative Vitreoretinopathy Type 2 (EVR2). This condition is a rare genetic disorder affecting the retina, leading to vision impairment or blindness. The test is crucial for early detection, enabling timely intervention and management of the condition to preserve vision and improve the quality of life for affected individuals.
The testing process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for any genetic abnormalities in the NDP gene. This test is particularly important for individuals with a family history of EVR2 or those showing symptoms related to vision problems, as it can confirm the diagnosis and guide treatment options.
The cost of the NDP Gene Exudative Vitreoretinopathy Type 2 Genetic Test at DNA Labs UAE is 4400 AED. While the price might seem high, the test offers invaluable insights into the genetic underpinnings of this condition, facilitating early and effective management strategies for those affected.
